June 2012

New Actos suits go straight to MDL

  • Fri, 06/29/2012 - 3:21pm

New lawsuits against Takeda Pharmaceuticals’ Type 2 diabetes drug Actos can move straight to the Multidistrict Litigation case thanks to a

Cleveland Clinic links diabetes drugs with increased death risk

  • Fri, 06/29/2012 - 2:38pm

Diabetes drugs glipizide, glyburide and glimepiride have recently been associated with a more than 50 percent higher mortality ri

FDA approves new diet pill

  • Thu, 06/28/2012 - 4:08pm

Despite nonprofit consumer watchdog group Public Citizen reminding the FDA about dangerous drug Fen-Phen earlier this week, the agency approve

FDA gives Bayer’s colon cancer drug “priority”

  • Thu, 06/28/2012 - 2:29pm

The U.S. Food and Drug Administration accepted Bayer’s experimental drug regorafenib for priority review, which could make it marketable in a matter of six months.

Soccer moms taking Adderall to get through daily stress

  • Wed, 06/27/2012 - 3:14pm

Overwhelmed mothers turn to popular ADHD drug when struggling with careers, family duties, or weight loss, ABC News reports.
 

Johnson & Johnson ignored FDA demand

  • Wed, 06/27/2012 - 10:11am

Johnson & Johnson sold its Gynecare Prolift vaginal mesh implant for nine months after the Food and Drug Administration ordered the implant to be taken off the market, Bloomberg News reported y

Approval of new blood-thinner put on hold

  • Tue, 06/26/2012 - 4:04pm

Pfizer Inc. and Bristol-Myers Squibb struggle to gain FDA approval for blood thinner Eliquis, a drug used to treat heart arrhythmia.

FDA approves Actavis' generic ADHD drug

  • Tue, 06/26/2012 - 3:34pm

The U.S. Food and Drug Administration recently created competition for Adderall XR manufacturer Shire PLC by approving another company’s generic form of the ADHD medication.
 

Toxic Side Effects of Onyx Drug Pose FDA Concerns

  • Fri, 06/22/2012 - 3:18pm

An experimental cancer drug from Onyx Pharmaceuticals arguably has more dangerous side effects than benefits for patients with a certain type of blood cancer, called multiple myeloma.
 

Warfarin alternatives create concerns

  • Fri, 06/22/2012 - 2:59pm

Pradaxa and Xarelto are blood thinners and alternatives to warfarin that cause concerns for heart doctors.   

Pages